Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Bausch Health Companies, Inc.

Bausch Health Companies, Inc. Recalls

All product recalls associated with Bausch Health Companies, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Feb 2024

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–6 of 6 recalls

Omeprazole Suspension (Bausch Health) – Subpotent Drug (2024)

Subpotent Drug: Out of specification for assay

Class IIModerate

FDAFeb 2, 2024Nationwide• Bausch Health Companies, Inc.

Mephyton (Bausch) - Impurity Specification Failure (2021)

Failed Impurities/Degradation Specifications

Class IIILow

FDAJun 8, 2021Nationwide• Bausch Health Companies, Inc.

Phytonadione Tablets (Bausch) - Impurity Specification Failure (2021)

Failed Impurities/Degradation Specifications

Class IIILow

FDA

Jun 8, 2021

Nationwide

• Bausch Health Companies, Inc.

Phytonadione Tablets (Bausch) – Impurity Specification (2021)

Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.

Class IIILow

FDAJan 7, 2021Nationwide• Bausch Health Companies, Inc.

Mephyton Tablets (Bausch) – Impurity Specification (2021)

Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.

Class IIILow

FDAJan 7, 2021Nationwide• Bausch Health Companies, Inc.

Hydrocortisone Butyrate Cream (Bausch) – Subpotent Drug (2020)

SUBPOTENT DRUG

Class IIModerate

FDAJul 13, 2020Nationwide• Bausch Health Companies, Inc.